MassLynx-Skyline Interface (MSI) – A New Automated Tool to Streamline MRM Method Development and Optimization for Large Molecule Quantification

Importance of the Topic

The reliable quantification of peptides and proteins using LC-MS/MS with multiple reaction monitoring (MRM) is critical in drug development, clinical biomarker analysis, and targeted proteomics. As large molecule analytes become more prevalent, streamlined workflows that reduce manual intervention while ensuring method robustness are increasingly valuable.

Objectives and Study Overview

This technology brief introduces the MassLynx-Skyline Interface (MSI), an automated solution designed to integrate Waters’ MassLynx software with the open-source Skyline platform. The primary objective is to simplify MRM method creation, optimization, and final acquisition for peptide and protein quantification.

Methodology and Instrumentation

The automated workflow comprises four sequential steps:

1. Precursor scouting to identify retention times of the most intense precursors.
2. Precursor→product screening to select top precursor/product pairs using default collision energies.
3. Transition filtering and collision energy optimization for the three to five most sensitive MRM transitions per peptide.
4. Final method assembly using optimized transitions and collision energies.

The MSI tool orchestrates method export from Skyline, data acquisition on a Waters tandem quadrupole instrument via MassLynx, and automated import, review, and filtering within Skyline.

Main Results and Discussion

Implementation of MSI eliminates repeated manual switching between software platforms. The interface intelligently manages tune files, LC methods, and injection parameters, while systematically naming and archiving all interim documents. Users experience a reduction in hands-on time and improved method reproducibility across operators.

Benefits and Practical Applications

• Enhanced throughput through end-to-end automation.
• Consistent collision energy optimization and transition selection.
• Reduced operator bias and error potential.
• Scalable for therapeutic peptide bioanalysis or multiplexed biomarker quantification.

Future Trends and Potential Uses

Future developments may integrate machine learning for predictive collision energy settings, expand support to hybrid mass spectrometers, and facilitate cloud-based collaboration. Such enhancements will further accelerate targeted assay development and accommodate growing sample cohorts.

Conclusion

The MassLynx-Skyline Interface streamlines MRM method development for peptides and proteins, delivering an intelligent, reproducible, and user-friendly workflow. By automating key steps, it significantly reduces hands-on time and ensures consistent analytical performance.

Reference

Tanna N, Dunning C, Molloy B. MassLynx-Skyline Interface (MSI): A New Automated Tool to Streamline MRM Method Development and Optimization for Large Molecule Quantification. Waters Corporation; April 2020.